Cargando…

Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis

BACKGROUND: Immunosuppressive agents in general are shown to prevent renal progression and all-cause mortality in idiopathic membranous nephropathy (IMN) patients with nephrotic syndrome. However, the efficacy and safety of different immunosuppressive treatments have not been systematic assessed and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Song, Wang, Ying, Xian, Li, Toyama, Tadashi, Jardine, Meg, Li, Guisen, Perkovic, Vlado, Hong, Daqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595305/ https://www.ncbi.nlm.nih.gov/pubmed/28898290 http://dx.doi.org/10.1371/journal.pone.0184398

Ejemplares similares

An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN
por: Ren, Song, et al.
Publicado: (2018)

Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
por: Bao, Neng, et al.
Publicado: (2023)

Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future?
por: Neuen, Brendon L, et al.
Publicado: (2020)

Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis
por: Bose, Bhadran, et al.
Publicado: (2022)

Immunosuppressive Treatment for Nephrotic Idiopathic Membranous Nephropathy: A Meta-Analysis Based on Chinese Adults
por: Xie, Guoqiang, et al.
Publicado: (2012)

Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis
por: Sukkar, Louisa, et al.
Publicado: (2016)

Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis
por: Liu, Jiarong, et al.
Publicado: (2022)

Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China
por: Xu, Wanyi, et al.
Publicado: (2023)

Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis
por: Zheng, Qiyan, et al.
Publicado: (2019)

Effects of the Mediterranean Diet on Cardiovascular Outcomes—A Systematic Review and Meta-Analysis
por: Liyanage, Thaminda, et al.
Publicado: (2016)

Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy: Protocol for an open-label randomized controlled clinical trial
por: Geng, Chanyu, et al.
Publicado: (2022)

Prediction Models of Primary Membranous Nephropathy: A Systematic Review and Meta-Analysis
por: Geng, Chanyu, et al.
Publicado: (2023)

Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic review
por: Smyth, Brendan, et al.
Publicado: (2019)

Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor
por: Oshima, Megumi, et al.
Publicado: (2020)

Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study
por: Jun, Min, et al.
Publicado: (2019)

The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis
por: Perkovic, Vlado, et al.
Publicado: (2008)

A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid Resuscitation
por: Feng, Yunlin, et al.
Publicado: (2022)

Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2017)

Helper T Cells in Idiopathic Membranous Nephropathy
por: Zhao, Qihan, et al.
Publicado: (2021)

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis
por: Jardine, Meg J, et al.
Publicado: (2012)

Comparison of the efficacy and safety of tacrolimus monotherapy and cyclophosphamide combined with glucocorticoid in the treatment of adult primary membranous nephropathy: protocol of a multicenter, randomized, controlled, open study
por: Chen, Shasha, et al.
Publicado: (2020)

Hirudin ameliorates immunoglobulin A nephropathy by inhibition of fibrosis and inflammatory response
por: Deng, Fei, et al.
Publicado: (2019)

A case of membranous immunotactoid glomerulopathy misdiagnosed as membranous nephropathy: significance of electron microscopy in kidney biopsy
por: Feng, Yunlin, et al.
Publicado: (2023)

Chapter 7: Idiopathic membranous nephropathy
Publicado: (2012)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Association of gut microbiota with idiopathic membranous nephropathy
por: Li, Mengfei, et al.
Publicado: (2022)

Advances of the experimental models of idiopathic membranous nephropathy
por: Jiang, Han Xue, et al.
Publicado: (2020)

Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis
por: Arnott, Clare, et al.
Publicado: (2020)

Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy
por: Cui, W., et al.
Publicado: (2017)

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis
por: Zhou, Zien, et al.
Publicado: (2021)

Clinical observation and analysis of thyroid hormone levels in patients with idiopathic membranous nephropathy
por: Huang, Yu, et al.
Publicado: (2020)

A nomogram prediction model for treatment failure in primary membranous nephropathy
por: Geng, Chanyu, et al.
Publicado: (2023)

Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
por: Lu, Huijuan, et al.
Publicado: (2022)

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
por: Heerspink, Hiddo J Lambers, et al.
Publicado: (2009)

Patient Age and the Prognosis of Idiopathic Membranous Nephropathy
por: Yamaguchi, Makoto, et al.
Publicado: (2014)

Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
por: Kennedy, Claire, et al.
Publicado: (2013)

Idiopathic Membranous Nephropathy and Treatment Related Complications
por: Uncanin, Snezana, et al.
Publicado: (2020)

Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis
por: Nataatmadja, Melissa, et al.
Publicado: (2021)

Astragalus membranaceus formula for moderate-high risk idiopathic membranous nephropathy: A meta-analysis
por: Wang, Dan, et al.
Publicado: (2023)

Clinicopathological features and prognosis in patients with idiopathic membranous nephropathy with hypertension
por: Lu, Wanjun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nquoqd38n8thfo6f1red5d563j